Park Ave Peptides — Clinical Reference Library — For Professional Use Only
Operational Updates
Editorial changes, quality updates, library expansions, and program announcements from the Park Ave Peptides reference team.
The clinical reference library has been expanded with eight new compound entries across the incretin, regenerative, and mitochondrial axes. Each entry follows the standard structure: molecular profile, mechanism, pharmacokinetics, handling, and selected citations.
Following a quality review, the endotoxin release specification has been tightened across the catalog. The updated threshold applies to all lots released from this date forward and is reflected on each new Certificate of Analysis.
Practitioners and researchers can now request a curated PDF citation packet for any compound entry in the reference library. Packets include the primary literature referenced in the entry, with DOI links and abstract summaries.
The Clinical Journal now features the Practitioner Spotlight series — in-depth conversations with clinicians and researchers about how they evaluate and reference peptide compounds in practice.
All inbound contact requests are now triaged and answered within one business day. Inquiries received before 2:00 PM ET typically receive a same-day reply from the relevant specialist.
A retained sample from every released lot is now held in controlled storage for the full shelf-life of that lot. The policy supports post-release investigation should any question arise about specific lot performance.
The full editorial process underlying the reference library has been published — covering source identification, drafting, peer review, QA, and revision. The page replaces the prior summary editorial note.
The Education Hub now includes a side-by-side comparison view for related peptides within the same therapeutic axis. Useful for practitioners evaluating compound family options at a glance.